Thimble Point Acquisition Corp. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Thimble Point Acquisition Corp. (“Thimble Point” or “Company”) (NASDAQ: THMA) with Pear Therapeutics, Inc. Under the terms of merger, Thimble Point stockholders will retain ownership of only 17% of the combined company.

The Thimble Point merger investigation concerns whether the Board of Thimble Point has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.